Medtronic diabetes announces ce mark for new simplera™ cgm with disposable all-in-one design

The company's newest simplera™ cgm is 50% smaller than its previous generation with a simple insertion and improved user experience dublin , sept. 21, 2023 /prnewswire/ -- medtronic plc (nyse:mdt), a global leader in healthcare technology, today announced ce (conformitÉ europÉenne) mark approval for its new all-in-one, disposable simplera™ continuous glucose monitor (cgm) featuring a simple, two-step insertion process.
MDT Ratings Summary
MDT Quant Ranking